Dr. Kim Margolin
Add to your Care-Team
Dr. Kim Margolin
Dr. Kim Margolin
Internal Medicine - Hematology
I specialize in
Internal Medicine - Hematology
Internal Medicine - Oncology
I have been in practice
My answers and insights have
Helped 6,652 people
Received 6 doctor agrees
Received 12 thanks
Here are kind words from others
Dr. Margolin is an amazing doctor! #nationaldoctorsday2015 #virtualflower1
I was educated and trained at
Medical / Graduate School
Stanford University School of Medicine, CA
Stanford University School of Medicine
Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512.
PLoS ONE., 7(11):e48787 (2012)
J Natl Compr Canc Netw., Apr;10(4):502-35 (2012)
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype.
Proc. Natl. Acad. Sci. U.S.A., Mar;109(12):4592-7 (2012)
An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.
Cancer., Sep;118(17):4098-104 (2012)
Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438).
Clin. Cancer Res., Feb;18(4):1129-37 (2012)
J Natl Compr Canc Netw., Sep;9(9):960-77 (2011)
Aflibercept (VEGF Trap) in inoperable stage III or stage iv melanoma of cutaneous or uveal origin.
Clin. Cancer Res., Oct;17(20):6574-81 (2011)
NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy.
J Natl Compr Canc Netw., Feb;9 Suppl 1:S1-29 (2011)
A phase II trial of gefitinib and pegylated IFNÎ± in previously treated renal cell carcinoma.
Int. J. Clin. Oncol., Oct;16(5):494-9 (2011)
Brain metastasis in melanoma: clinical activity of CTLA-4 antibody therapy.
Semin. Oncol., Oct;37(5):468-72 (2010)
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial.
Invest New Drugs., Apr;30(2):741-8 (2012)
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.
J. Clin. Oncol., Nov;28(33):4906-11 (2010)
Indoor tanning and substance-related disorder--related behaviors with similar treatment?
Curr Oncol Rep., Sep;12(5):288-9 (2010)
Indoor tanning use among U.S. youth--can skin health behaviors be legislated?
Curr Oncol Rep., Sep;12(5):290-1 (2010)
Cytokine working group study of lymphodepleting chemotherapy, interleukin-2, and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma: clinical outcomes and peripheral-blood cell recovery.
J. Clin. Oncol., Mar;28(7):1196-202 (2010)
Inside life of melanoma cell signaling, molecular insights, and therapeutic targets.
Curr Oncol Rep., Sep;11(5):405-11 (2009)
Control of experimental melanoma by host CXCR2.
Curr Oncol Rep., Sep;11(5):333-4 (2009)
CCR9:CCL25 in melanoma metastatic to small intestine.
Curr Oncol Rep., Sep;11(5):331-2 (2009)
NCCN clinical practice guidelines in oncology: kidney cancer.
J Natl Compr Canc Netw., Jun;7(6):618-30 (2009)
NCCN clinical practice guidelines in oncology: testicular cancer.
J Natl Compr Canc Netw., Jun;7(6):672-93 (2009)
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study.
Cancer Chemother. Pharmacol., Nov;64(6):1149-55 (2009)
Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer.
J. Clin. Oncol., May;27(13):2163-9 (2009)
State of the science 60th anniversary review: 60 Years of advances in cutaneous melanoma epidemiology, diagnosis, and treatment, as reported in the journal Cancer.
Cancer., Oct;113(7 Suppl):1728-43 (2008)
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study.
Cancer., Oct;113(8):2139-45 (2008)
The significance of solid tumor stem cells in melanoma: Part 1.
Curr Oncol Rep., Sep;10(5):429 (2008)
The significance of solid tumor stem cells in melanoma: Part 2.
Curr Oncol Rep., Sep;10(5):430 (2008)
Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma.
J. Clin. Oncol., May;26(14):2292-8 (2008)
Phase I/II trial of outpatient PEG-interferon with interleukin-2 in advanced renal cell carcinoma: a cytokine working group study.
J. Immunother., 30(8):839-46 (2007 Nov-Dec)
An introduction to foundation and industry-sponsored research: practical and ethical considerations.
Hematology Am Soc Hematol Educ Program., 498-503 (2007)
Sunitinib efficacy against advanced renal cell carcinoma.
J. Urol., Nov;178(5):1883-7 (2007)
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
J. Clin. Oncol., Jan;25(3):247-56 (2007)
Kidney cancer. Clinical practice guidelines in oncology.
J Natl Compr Canc Netw., Nov;4(10):1072-81 (2006)
Testicular cancer. Clinical practice guidelines in oncology.
J Natl Compr Canc Netw., Nov;4(10):1038-58 (2006)
Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.
Biol. Blood Marrow Transplant., Jul;12(7):778-85 (2006)
Sunitinib in patients with metastatic renal cell carcinoma.
JAMA., Jun;295(21):2516-24 (2006)
Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies.
Cancer., Jun;106(12):2624-9 (2006)
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancer.
Biol. Blood Marrow Transplant., Nov;11(11):903-11 (2005)
Kidney cancer. Clinical practice guidelines.
J Natl Compr Canc Netw., Jan;3(1):84-93 (2005)
Testicular cancer. Clinical practice guidelines.
J Natl Compr Canc Netw., Jan;3(1):52-76 (2005)
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma.
J. Clin. Oncol., Jan;23(1):133-41 (2005)
Biochemotherapy for melanoma: rational therapeutics in the search for weapons of melanoma destruction.
Cancer., Aug;101(3):435-8 (2004)
A study of radiotherapy modalities combined with continuous 5-FU infusion for locally advanced gastrointestinal malignancies.
Eur J Surg Oncol., Aug;30(6):650-7 (2004)
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma.
Biol. Blood Marrow Transplant., 5(1):36-45 (1999)
Cellular immunotherapy and autologous transplantation for hematologic malignancy.
Immunol. Rev., Jun;157:231-40 (1997)
Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells.
Leukemia., May;11(5):723-8 (1997)
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.
J. Clin. Oncol., Aug;14(8):2206-16 (1996)
Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma.
J. Clin. Oncol., Apr;11(4):661-70 (1993)
Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia.
J. Clin. Oncol., Sep;9(9):1570-4 (1991)
Phase I study of high-dose continuous-infusion recombinant interleukin-2 and autologous lymphokine-activated killer cells in patients with metastatic or unresectable malignant melanoma and renal cell carcinoma.
J. Natl. Cancer Inst., Sep;82(17):1397-402 (1990)
Dr. Kim Margolin F
Dr i came to know that breast cancer causes misscarriage, is it true? Breast cancer causes early stage miscarriages?! In brief: NOBREAST CANCER BREAST CARCINOMA CANCER MISCARRIAGE FEMALE HEALTH
but any treatment for breast cancer other than surgery could cause fetal abnormalities use ultrasound instead of mammogram to safely image the breast and guide biopsy if needed.
I had what looked like a hard pimple on the bottom of my foot that I popped and now it wont stop bleeding. Is this a blood blister? what should I do? In brief: UnlikelyBLOOD BLISTER PIMPLES
you may have disrupted a blood vessel close to the skin or it's possible that you have infection or less likely malignancy.
3 mets at present small , organs all fine , bloods fine , but chemo not responding . Mets may b ablated . How long can the person live now ? In brief: May be operable
to the point of not returning at all (surgically curable) although low overall chance for surgery to get out every last metastasis and cure you that way.
but a temporary reemission is possible and would work better than ineffective chemotherapyCHEMOTHERAPY METASTASIS
Approx how many mets and how big should they be to call colon cancer terminal ? In brief: Not numericalCANCER COLON CANCER COLONIC METASTASIS
if there is any evidence of spread that cannot be removed surgically it is considered incurable and the treatments would involve chemotherapy, biological therapies and possibly radiation.